BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9078321)

  • 1. Intracranial Hodgkin's disease in two patients with familial Hodgkin's disease.
    Ashigbi MY; Venkatraj U; Agarwal V; Bello J; Wiernik PH
    Med Pediatr Oncol; 1997 Apr; 28(4):255-8. PubMed ID: 9078321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
    Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial presentation of systemic Hodgkin's disease.
    Hirmiz K; Foyle A; Wilke D; Burrell S; Brownstone R; Ago C; Pahil R; Couban S
    Leuk Lymphoma; 2004 Aug; 45(8):1667-71. PubMed ID: 15370222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease presenting with isolated craniospinal involvement.
    Bender BL; Mayernik DG
    Cancer; 1986 Oct; 58(8):1745-8. PubMed ID: 3756795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
    Preti A; Hagemeister FB; McLaughlin P; Swan F; Rodriguez A; Besa P; Cox JD; Allen PK; Cabanillas F
    Ann Oncol; 1994; 5 Suppl 2():97-100. PubMed ID: 7515653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
    De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
    Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
    Schoeffler A; Levy E; Weinborn M; Cuny JF; Schmutz JL; Barbaud A; Cribier B; Bursztejn AC
    Ann Dermatol Venereol; 2014 Feb; 141(2):134-40. PubMed ID: 24507208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial Hodgkin's disease: a primary presentation and access of cytotoxic agents.
    Ashby MA; Bowen D; Watson JV
    Br J Radiol; 1986 Dec; 59(708):1241-2. PubMed ID: 3801807
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
    Tsyplenkov VG; Sviridova AV
    Med Radiol (Mosk); 1984 Oct; 29(10):34-7. PubMed ID: 6548787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K; Utsumi M; Shimoyama M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningeal localization in a patient with Hodgkin's disease. Description of a case and review of the literature.
    Anselmo AP; Proia A; Cartoni C; Baroni CD; Maurizi Enrici R; Delfini R; Avvisati G
    Ann Oncol; 1996 Dec; 7(10):1071-5. PubMed ID: 9037367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
    Silingardi V; Federico M; Frassoldati A; Barbieri F; Palomba G; Mauri C
    Acta Haematol; 1989; 82(4):179-86. PubMed ID: 2511719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma of the central nervous system after treatment of Hodgkin's disease.
    Miller DC; Knee R; Schoenfeld S; Wasserstrom WR; Karp G
    Am J Clin Pathol; 1989 Apr; 91(4):481-5. PubMed ID: 2929506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
    Adiga GU; Abebe L; Wiernik PH
    Am J Hematol; 2003 Apr; 72(4):267-73. PubMed ID: 12666139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
    Straus DJ; Myers J; Koziner B; Lee BJ; Clarkson BD
    Cancer Chemother Pharmacol; 1983; 11(2):80-5. PubMed ID: 6194913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
    Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABVD and radiation therapy as first-line treatment in advanced Hodgkin's disease.
    Zinzani PL; Magagnoli M; Frezza G; Barbieri E; Gherlinzoni F; Galuppi A; Bendandi M; Merla E; Albertini P; Babini L; Tura S
    Leuk Lymphoma; 1999 Feb; 32(5-6):553-9. PubMed ID: 10048428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
    Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.